UK markets open in 3 hours 38 minutes
NIKKEI 225
38,392.10 +189.73 (+0.50%) HANG SENG
18,452.42 +138.56 (+0.76%) CRUDE OIL
79.43 +0.44 (+0.56%) GOLD FUTURES
2,318.60 -3.70 (-0.16%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,144.25 -1,061.75 (-2.11%)
Rigel Pharmaceuticals Inc (RI2A.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 08:03AM CEST
| Previous close | 1.1320 |
| Open | 1.0070 |
| Bid | 0.9035 x 500000 |
| Ask | 0.9425 x 500000 |
| Day's range | 1.0070 - 1.0070 |
| 52-week range | 0.6678 - 1.6345 |
| Volume | |
| Avg. volume | 331 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript May 7, 2024 Rigel Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the First Quarter 2024. At this time, […]
- GuruFocus.com
Rigel Pharmaceuticals Inc (RIGL) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves ...
Explore key financial outcomes and strategic directions from Rigel Pharmaceuticals' first quarter earnings call of 2024.
- Zacks
Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Lags Revenue Estimates
Rigel (RIGL) delivered earnings and revenue surprises of -66.67% and 5.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.